|   |
|---|
|   |  |  |
| x |   | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|   |
|---|
|   |  |  |
| o |   | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|                                          |
|------------------------------------------|
|                                          |  |  |
| Nevada                                   |   | 91-2015186 |
| (State or other jurisdiction of          |   | (I.R.S. Employer |
| incorporation or organization)           |   | Identification No.) |
|                                     |   |   |
| 2301 Crown Court, Irving, Texas          |   | 75038 |
| (Address of principal executive offices) |   | (Zip Code) |

|                                   |
|-----------------------------------|
|                                   |  |  |  |  |
| Large accelerated filer | o |    | Accelerated filer | o |
| Non-accelerated filer        | o | (Do not check if a smaller reporting company) | Smaller reporting company | x |

|                                          |
|------------------------------------------|
|                                          |  |  |
| Class                                    |   | Outstanding at April 29, 2011 |
| Common Stock, $0.001 par value per share |   | 22,228,834 shares |

----

|                                      |
|--------------------------------------|
|                                      |  |  |
|                                 | Page Number |
| PART I – FINANCIAL INFORMATION |   |
|                                 |   |   |
| Item 1.                              | Financial Statements | 3 |
| Item 2.                              | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 12 |
| Item 3.                              | Quantitative and Qualitative Disclosures About Market Risk | 15 |
| Item 4.                              | Controls and Procedures | 16 |
|                                 |   |   |
| PART II – OTHER INFORMATION    |   |
|                                 |   |   |
| Item 1.                              | Legal Proceedings | 17 |
| Item 1A.                             | Risk Factors | 17 |
| Item 2.                              | Unregistered Sales of Equity Securities and Use of Proceeds | 17 |
| Item 3.                              | Defaults Upon Senior Securities | 17 |
| Item 4.                              | Reserved | 17 |
| Item 5.                              | Other Information | 17 |
| Item 6.                              | Exhibits | 17 |
|                                 |   |   |
| Signatures                           | 18 |
|                                 |   |
| Exhibit Index                        | 19 |

----

|                                                                                                                                                |
|------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                |  |  |  |  |  |  |  |
|                                                                                                                                           | March 31, 2011 |   | December 31, 2010 |
|                                                                                                                                           | (Unaudited) |   |   |
| ASSETS                                                                                                                                         |   |   |   |
| Current assets:                                                                                                                                |   |   |   |
| Cash and cash equivalents                                                                                                                      | $ | 5,447,730 |   |   | $ | 4,220,152 |   |
| Accounts receivable, net                                                                                                                       | 563,234 |   |   | 491,576 |   |
| Inventories                                                                                                                                    | 4,741,869 |   |   | 5,343,016 |   |
| Deferred income taxes                                                                                                                          | 359,615 |   |   | 396,415 |   |
| Prepaid expenses                                                                                                                               | 861,262 |   |   | 807,344 |   |
| Total current assets                                                                                                                           | 11,973,710 |   |   | 11,258,503 |   |
| Property and equipment, net                                                                                                                    | 4,545,677 |   |   | 4,638,075 |   |
| Goodwill, net                                                                                                                                  | 2,311,177 |   |   | 2,295,270 |   |
| Intangible assets, net                                                                                                                         | 54,362 |   |   | 55,851 |   |
| Other assets                                                                                                                                   | 123,016 |   |   | 95,813 |   |
|                                                                                                                                           | $ | 19,007,942 |   |   | $ | 18,343,512 |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                     |   |   |   |   |   |
| Current liabilities:                                                                                                                           |   |   |   |   |   |
| Accounts payable, trade                                                                                                                        | $ | 1,774,154 |   |   | $ | 2,110,624 |   |
| Accrued liabilities                                                                                                                            | 1,162,830 |   |   | 976,495 |   |
| Current maturities of long-term obligations                                                                                                    | 171,808 |   |   | 168,522 |   |
| Deferred revenue                                                                                                                               | 3,194,822 |   |   | 2,489,828 |   |
| Total current liabilities                                                                                                                      | 6,303,614 |   |   | 5,745,469 |   |
| Long-term obligations, less current maturities                                                                                                 | 1,683,351 |   |   | 1,727,555 |   |
| Deferred income taxes                                                                                                                          | 994,907 |   |   | 994,909 |   |
| Shareholders’ equity:                                                                                                                    |   |   |   |   |
| Common stock, $0.001 par value; 50,000,000 shares authorized; 22,228,834 shares issued and outstanding at March 31, 2011 and December 31, 2010 | 22,229 |   |   | 22,229 |   |
| Additional paid-in capital                                                                                                                     | 13,616,291 |   |   | 13,605,922 |   |
| Accumulated deficit                                                                                                                            | (3,738,014 | ) |   | (3,881,348 | ) |
| Accumulated other comprehensive income                                                                                                         | 125,564 |   |   | 128,776 |   |
|                                                                                                                                           | 10,026,070 |   |   | 9,875,579 |   |
|                                                                                                                                           | $ | 19,007,942 |   |   | $ | 18,343,512 |   |

----

|                               |
|-------------------------------|
|                               |  |  |  |  |  |  |  |
|                          | For the Quarters Ended March 31, |
|                          | 2011 |   | 2010 |
| Net sales                     | $ | 6,537,883 |   |   | $ | 6,981,530 |   |
| Cost of sales                 | 3,221,718 |   |   | 3,592,735 |   |
| Gross profit                  | 3,316,165 |   |   | 3,388,795 |   |
| Operating expenses:           |   |   |   |   |   |
| General and administrative    | 2,110,015 |   |   | 2,325,384 |   |
| Distributor commissions       | 834,564 |   |   | 540,745 |   |
| Depreciation and amortization | 110,043 |   |   | 122,371 |   |
| Total operating expenses      | 3,054,622 |   |   | 2,988,500 |   |
| Operating profit              | 261,543 |   |   | 400,295 |   |
| Interest expense              | 36,209 |   |   | 39,271 |   |
| Earnings before income taxes  | 225,334 |   |   | 361,024 |   |
| Provision for income taxes    | 82,000 |   |   | 149,700 |   |
| Net earnings                  | $ | 143,334 |   |   | $ | 211,324 |   |

|                     |
|---------------------|
|                     |  |  |  |
| Earnings per share: |   |   |   |
|   Basic   | $0.01 |   | $0.01 |
|   Diluted | $0.01 |   | $0.01 |

|                                             |
|---------------------------------------------|
|                                             |  |  |  |  |  |
| Weighted average common shares outstanding: |   |   |   |
|   Basic                           | 22,228,834 |   |   | 21,921,934 |   |
|   Diluted                         | 22,540,810 |   |   | 22,269,942 |   |

----

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |  |  |  |  |
|                                                 | For the Quarters Ended March 31, |
|                                                 | 2011 |   | 2010 |
| Cash flows from operating activities:                |   |   |   |
| Net earnings                                         | $ | 143,334 |   |   | $ | 211,324 |   |
| Adjustment for non-cash items:                       |   |   |   |
| Depreciation and amortization                        | 127,300 |   |   | 138,305 |   |
| Stock-based compensation                             | 10,369 |   |   | 33,212 |   |
| Deferred income taxes                                | 38,500 |   |   | 11,442 |   |
| Change in operating assets and liabilities:          |   |   |   |
| Accounts receivable                                  | (71,598 | ) |   | 81,700 |   |
| Inventories                                          | 604,199 |   |   | 306,197 |   |
| Prepaid expenses                                     | (142,819 | ) |   | (76,011 | ) |
| Other assets                                         | (27,120 | ) |   | — |   |
| Accounts payable and accrued liabilities             | (63,184 | ) |   | (224,282 | ) |
| Deferred revenue                                     | 704,852 |   |   | (819,605 | ) |
| Net cash provided by (used in) operating activities  | 1,323,833 |   |   | (337,718 | ) |
| Cash flows from investing activities:                |   |   |   |   |   |
| Purchase of property and equipment                   | (33,413 | ) |   | (53,664 | ) |
| Net cash used in investing activities                | (33,413 | ) |   | (53,664 | ) |
| Cash flows from financing activities:                |   |   |   |   |   |
| Payments of long-term obligations                    | (40,918 | ) |   | (37,876 | ) |
| Net cash used in financing activities                | (40,918 | ) |   | (37,876 | ) |
| Effect of exchange rate changes on cash flows        | (21,924 | ) |   | (21,700 | ) |
| Net increase (decrease) in cash and cash equivalents | 1,227,578 |   |   | (450,958 | ) |
| Cash and cash equivalents, beginning of period       | 4,220,152 |   |   | 3,972,111 |   |
| Cash and cash equivalents, end of period             | $ | 5,447,730 |   |   | $ | 3,521,153 |   |

----

----

|                                 |
|---------------------------------|
|                                 |  |  |  |  |  |  |  |
|                            | March 31, 2011 |   | December 31, 2010 |
| Raw materials and bulk products | $ | 407,925 |   |   | $ | 287,644 |   |
| Packaging materials             | 323,749 |   |   | 318,397 |   |
| Finished goods                  | 4,010,195 |   |   | 4,736,975 |   |
|                            | $ | 4,741,869 |   |   | $ | 5,343,016 |   |

|                                      |
|--------------------------------------|
|                                      |  |  |  |  |  |  |  |
|                                 | March 31, 2011 |   | December 31, 2010 |
| Advance payment to suppliers         | $ | 474,326 |   |   | $ | 333,763 |   |
| Prepaid income taxes                 | — |   |   | 225,698 |   |
| Certificates of deposit - restricted | 87,431 |   |   | 84,923 |   |
| Prepaid insurance and other          | 299,505 |   |   | 162,960 |   |
|                                 | $ | 861,262 |   |   | $ | 807,344 |   |

|                                        |
|----------------------------------------|
|                                        |  |  |  |  |  |  |  |
|                                   | March 31, 2011 |   | December 31, 2010 |
| Building and improvements              | $ | 3,523,428 |   |   | $ | 3,523,428 |   |
| Computer software and office equipment | 2,089,009 |   |   | 2,063,488 |   |
| Warehouse equipment                    | 226,922 |   |   | 219,030 |   |
| Automotive equipment                   | 15,228 |   |   | 15,228 |   |
|                                   | 5,854,587 |   |   | 5,821,174 |   |
| Less – accumulated depreciation  | (2,450,083 | ) |   | (2,324,272 | ) |
|                                   | 3,404,504 |   |   | 3,496,902 |   |
| Land                                   | 1,141,173 |   |   | 1,141,173 |   |
|                                   | $ | 4,545,677 |   |   | $ | 4,638,075 |   |

|                                 |
|---------------------------------|
|                                 |  |  |  |  |  |  |  |
|                            | Gross Carrying Value |   | Accumulated Amortization |
| Balance, December 31, 2010      | $ | 3,429,940 |   |   | $ | (1,134,670 | ) |
| Currency translation adjustment | 31,039 |   |   | (15,132 | ) |
| Balance, March 31, 2011         | $ | 3,460,979 |   |   | $ | (1,149,802 | ) |

----

|                                                |
|------------------------------------------------|
|                                                |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                           |   |   | March 31, 2011 |   | December 31, 2010 |
|                                           | AverageLife(years) |   | GrossCarryingValue |   | AccumulatedAmortization |   | GrossCarryingValue |   | AccumulatedAmortization |
| Copyrights, trademarks and other registrations | 19 |   | $ | 99,100 |   |   | $ | (50,870 | ) |   | $ | 99,100 |   |   | $ | (49,549 | ) |
| Other                                          | 19 |   | 12,600 |   |   | (6,468 | ) |   | 12,600 |   |   | (6,300 | ) |
|                                           |   |   | $ | 111,700 |   |   | $ | (57,338 | ) |   | $ | 111,700 |   |   | $ | (55,849 | ) |

|                   |
|-------------------|
|                   |  |  |  |
| Remainder of 2011 | $ | 4,468 |   |
| 2012              | 5,957 |   |
| 2013              | 5,957 |   |
| 2014              | 5,957 |   |
| 2015              | 5,957 |   |
| Thereafter        | 26,066 |   |
|              | $ | 54,362 |   |

|                          |
|--------------------------|
|                          |  |  |  |  |  |  |  |
|                     | March 31, 2011 |   | December 31, 2010 |
| Distributor commissions  | $ | 543,868 |   |   | $ | 470,778 |   |
| Salaries and wages       | 487,329 |   |   | 399,357 |   |
| Sales and property taxes | 55,241 |   |   | 31,422 |   |
| Interest                 | 11,981 |   |   | 12,246 |   |
| Other                    | 64,411 |   |   | 62,692 |   |
|                     | $ | 1,162,830 |   |   | $ | 976,495 |   |

|                                                                                                                                                                                                                                                         |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                         |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                    | March 31, 2011 |   | December 31, 2010 |
| Mortgage note payable bearing interest at 7.75%, payable in monthly installments of $25,797 through April 2019, collateralized by land and building, and personally guaranteed by the Company’s Chairman of the Board and Chief Executive Officer | $ | 1,855,159 |   |   | $ | 1,896,077 |   |
| Less – current maturities                                                                                                                                                                                                                         | (171,808 | ) |   | (168,522 | ) |
|                                                                                                                                                                                                                                                    | $ | 1,683,351 |   |   | $ | 1,727,555 |   |

----

|                                        |
|----------------------------------------|
|                                        |  |  |  |  |  |
|                                   | Quarters Ended March 31, |
|                                   | 2011 |   | 2010 |
|                                   |   |   | (1) |
| Weighted average expected life (years) | 8.4 |   |   | — |   |
| Risk-free interest rate                | 3.32 | % |   | — | % |
| Expected volatility                    | 96.23 | % |   | — | % |
| Expected dividend yield                | — | % |   | — | % |

|                                  |
|----------------------------------|
|                                  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                             | Options |   | Weighted-Average Exercise Price per Share |   | Weighted-Average Remaining Contractual Term (in years) |   | Aggregate Intrinsic Value |
| Outstanding on December 31, 2010 | 1,198,390 |   |   | $ | 0.34 |   |   |                                        |   |   |
| Granted                          | 33,600 |   |   | 0.28 |   |   |   |   |   |
| Exercised                        | — |   |   | — |   |   |   |   |   |
| Forfeited/canceled               | (28,570 | ) |   | 0.39 |   |   |   |   |   |
| Outstanding on March 31, 2011    | 1,203,420 |   |   | $ | 0.34 |   |   | 3.7 |   |   | $ | 118,265 |   |
| Exercisable on March 31, 2011    | 927,640 |   |   | $ | 0.28 |   |   | 3.3 |   |   | $ | 116,297 |   |

|                                               |
|-----------------------------------------------|
|                                               |  |  |  |  |  |  |
|                                          | Shares |   | Weighted-Average Grant Date Fair Value per Share |
| Non-vested stock options at December 31, 2010 | 303,930 |   |   | $ | 0.46 |   |
| Non-vested stock options granted              | — |   |   | — |   |
| Vested stock options                          | — |   |   | — |   |
| Forfeited stock options                       | (28,150 | ) |   | 0.35 |   |
| Non-vested stock options at March 31, 2011    | 275,780 |   |   | 0.48 |   |

----

|                                             |
|---------------------------------------------|
|                                             |  |  |  |  |  |  |  |  |  |  |  |
|                                        | Nutritional Products |   | Medical Products |   | Consolidated |
| Quarter Ended March 31, 2011      |   |   |   |   |   |   |   |   |
| Net sales                                   | $ | 4,815 |   |   | $ | 1,723 |   |   | $ | 6,538 |   |
| Depreciation and amortization               | 109 |   |   | 18 |   |   | 127 |   |
| Operating profit                            | 158 |   |   | 104 |   |   | 262 |   |
| Capital expenditures                        | 33 |   |   | — |   |   | 33 |   |
| Total assets                                | 16,381 |   |   | 2,627 |   |   | 19,008 |   |
| Quarter Ended March 31, 2010 |   |   |   |   |   |   |   |   |
| Net sales                                   | $ | 5,414 |   |   | $ | 1,568 |   |   | $ | 6,982 |   |
| Depreciation and amortization               | 117 |   |   | 21 |   |   | 138 |   |
| Operating profit                            | 369 |   |   | 31 |   |   | 400 |   |
| Capital expenditures                        | 54 |   |   | — |   |   | 54 |   |
| Total assets                                | 15,126 |   |   | 2,654 |   |   | 17,780 |   |

|                       |
|-----------------------|
|                       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                  | Quarter Ended March 31, 2011 |   | Quarter Ended March 31, 2010 |
|                  | Net sales |   | Long-Lived assets |   | Net sales |   | Long-Lived assets |
| Domestic              | $ | 2,958 |   |   | $ | 6,476 |   |   | $ | 2,599 |   |   | $ | 6,747 |   |
| Russia/Eastern Europe | 3,057 |   |   | — |   |   | 3,971 |   |   | — |   |
| Canada                | 318 |   |   | 558 |   |   | 230 |   |   | 567 |   |
| All others            | 205 |   |   | — |   |   | 182 |   |   | — |   |
| Totals                | $ | 6,538 |   |   | $ | 7,034 |   |   | $ | 6,982 |   |   | $ | 7,314 |   |

----

|                                        |
|----------------------------------------|
|                                        |  |  |  |  |  |  |  |  |  |  |
|                                   | Net Earnings |   | WeightedAverageShares |   | Per Share |
| Quarter Ended March 31, 2011 |   |   |   |   |   |   |   |   |
| Basic earnings per common share        | $ | 143,334 |   |   | 22,228,834 |   |   | $ | 0.01 |   |
| Effect of dilutive stock options       | — |   |   | 311,976 |   |   |   |   |
| Diluted earnings per common share      | $ | 143,334 |   |   | 22,540,810 |   |   | $ | 0.01 |   |
| Quarter Ended March 31, 2010           |   |   |   |   |   |   |   |   |
| Basic earnings per common share        | $ | 211,324 |   |   | 21,921,934 |   |   | $ | 0.01 |   |
| Effect of dilutive stock options       | — |   |   | 348,008 |   |   |   |   |
| Diluted earnings per common share      | $ | 211,324 |   |   | 22,269,942 |   |   | $ | 0.01 |   |

|                                         |
|-----------------------------------------|
|                                         |  |  |  |  |  |  |  |
|                                    | Quarters Ended March 31, |
|                                    | 2011 |   | 2010 |
| Net earnings                            | $ | 143,334 |   |   | $ | 211,324 |   |
| Other comprehensive income:             |   |   |   |
| Foreign currency translation adjustment | (3,212 | ) |   | 1,158 |   |
| Comprehensive income                    | $ | 140,122 |   |   | $ | 212,482 |   |

----

|         |                                                                                        |
|---------|----------------------------------------------------------------------------------------|
| ITEM 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Through the Nutritional Products segment, we distribute products in three broad categories: (i) wellness products, (ii) fitness products and (iii) skin care products.   Products include herbal formulas, vitamins, minerals, antioxidants and personal care products.  In certain markets, principally in the U.S., Canada and Southeast Asia, we distribute Nutritional Products directly through a network comprised of independent Associates and individuals who participate in our NFR program. In certain other markets, we distribute Nutritional Products through exclusive license arrangements with third parties who, for the most part, distribute our products through an independent Associate network in the licensed territory. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Through the Medical Products segment, we distribute wound care products.  These products are distributed mainly in the U.S. to hospitals, nursing homes, clinics and pharmacies through traditional medical/surgical supply dealers and pharmaceutical distributors.  Medical Products are used to prevent and treat wounds, and manage pain associated with wounds, in the acute care, long-term care and oncology markets. |

|                       |
|-----------------------|
|                       |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                  | Quarters Ended March 31, |
|                  | 2011 |   | 2010 |
|                  | (U.S. dollars in 000’s) |
| Nutritional Products: |   |   |   |   |   |   |   |
| Licensees             | $ | 3,089 |   |   | 47 | % |   | $ | 4,153 |   |   | 60 | % |
| Associate network     | 1,726 |   |   | 27 | % |   | 1,261 |   |   | 18 | % |
|                  | 4,815 |   |   | 74 | % |   | 5,414 |   |   | 78 | % |
| Medical Products      | 1,723 |   |   | 26 | % |   | 1,568 |   |   | 22 | % |
|                  | $ | 6,538 |   |   | 100 | % |   | $ | 6,982 |   |   | 100 | % |

----

|                |
|----------------|
|                |  |  |  |  |  |
|           | Quarters Ended March 31, |
|           | 2011 |   | 2010 |
| U.S.           | 73 | % |   | 82 | % |
| Canada         | 18 |   |   | 18 |   |
| Southeast Asia | 9 |   |   | — |   |
|           | 100 | % |   | 100 | % |

----

|                               |
|-------------------------------|
|                               |  |  |  |  |  |
|                          | Quarters Ended March 31, |
|                          | 2011 |   | 2010 |
| Net sales                     | 100.0 | % |   | 100.0 | % |
| Cost of sales                 | 49.3 |   |   | 51.5 |   |
| Gross profit                  | 50.7 |   |   | 48.5 |   |
| Operating expenses:           |   |   |   |   |   |
| General and administrative    | 32.3 |   |   | 33.3 |   |
| Distributor commissions       | 12.8 |   |   | 7.7 |   |
| Depreciation and amortization | 1.6 |   |   | 1.8 |   |
| Total operating expenses      | 46.7 |   |   | 42.8 |   |
| Operating profit              | 4.0 |   |   | 5.7 |   |
| Interest expense              | 0.6 |   |   | 0.5 |   |
| Earnings before income taxes  | 3.4 |   |   | 5.2 |   |
| Provision for income taxes    | 1.2 |   |   | 2.2 |   |
| Net earnings                  | 2.2 | % |   | 3.0 | % |

----

|         |                                                             |
|---------|-------------------------------------------------------------|
| ITEM 3. | Quantitative and Qualitative Disclosures About Market Risk. |

----

|         |                          |
|---------|--------------------------|
| ITEM 4. | Controls and Procedures. |

----

|         |                    |
|---------|--------------------|
| ITEM 1. | Legal Proceedings. |

|          |               |
|----------|---------------|
| ITEM 1A. | Risk Factors. |

|         |                                                              |
|---------|--------------------------------------------------------------|
| ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds. |

|         |                                  |
|---------|----------------------------------|
| ITEM 3. | Defaults Upon Senior Securities. |

|         |           |
|---------|-----------|
| ITEM 4. | Reserved. |

|         |                    |
|---------|--------------------|
| ITEM 5. | Other Information. |

|         |           |
|---------|-----------|
| ITEM 6. | Exhibits. |

----

|                  |
|------------------|
|                  |  |  |  |
|             |   | RBC Life Sciences, Inc. |
|             |   | Registrant |
|             |   |   |   |
| May 6, 2011 |   | By: | /s/             Clinton H. Howard |
| Date             |   | Its: | President and Chief Executive Officer |
|             |   |   |   |
| May 6, 2011 |   | By: | /s/              Steven E. Brown |
| Date             |   | Its: | Vice President-Finance and |
|             |   |   | Chief Financial Officer |
|             |   |   | (Principal Financial and Accounting Officer) |

----

|                     |
|---------------------|
|                     |  |
| Exhibit Number | Description |
| 31.1                | Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|                |   |
| 31.2                | Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|                |   |
| 32.1                | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|                |   |
| 32.2                | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |